A shadow economy for unlicensed slimming medications is being driven by TikTok fitness influencers and vendors on communication apps, according to new investigations.
Experimental Treatment Gaining Traction Via Social Media
The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its supposed weight-reducing effects. Viewers are encouraged to message these accounts privately for source information, while also receiving discount codes.
Thriving Commerce on Messaging Platforms
Separately, a flourishing market exists on Telegram, where groups with thousands of members share “before and after” photos, administration instructions and claims of rapid UK delivery. Sellers market the drug there before redirecting buyers to other platforms for transactions.
Learning About Retatrutide
Retatrutide is an experimental injectable created by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could assist patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being hailed online as the successor to Ozempic.
Medical Professionals Express Concerns
Nevertheless, physicians and chemists have cautions that the distribution of what remains an unapproved medication in the UK is a cause for concern and could lead to users injecting substances of unknown origin.
Some experts said the popularity for retatrutide could be linked to the rising cost of licensed weight loss products such as Mounjaro.
Legal Status and Implementation
Selling retatrutide on TikTok or Telegram is illegal in the United Kingdom, as it is an unapproved medication that cannot be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.
Some content creators try to sidestep the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and supply can still violate pharmaceutical, advertising, and consumer laws, potentially leading to penalties, prosecution or imprisonment.
Platform Reaction and Content Elimination
According to the social media company, the platform has taken down violative material and prohibited related keywords and query recommendations. The company said it was committed to keeping the service safe and allocating resources in enhancing compliance measures.
Digital Trading Activities
Research also found communities with up to 9,000 participants marketing the experimental drug using the platform's built-in search feature, which functions like a online catalog. Typing “retatrutide” instantly displays groups with thousands of members, populated with images of slimming results, glowing reviews and detailed instructions for mixing or administering at home.
After minutes of joining one community, a seller shared contact information, where most purchases take place. The seller provided an guidebook and guaranteed delivery within 48 hours. When questioned whether the substance was genuine, one vendor said: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. None inquired about weight, health issues or past usage.
Item Information and Costs
Within these groups, messages display dark colored parcels with Royal Mail stickers, claiming to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, prepared at home with sterile water, or ready-to-use injectors typically sold at 160 pounds for 20mg. When asked how long a injector should be used, vendors give contradictory responses ranging from a few weeks to “depends on your body”.
Platform Moderation and Security Measures
A spokesperson for Telegram said it regularly monitored harmful material on its service including material that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Cautions
“People are injecting materials they cannot confirm. Although the research behind retatrutide is sound, these digital products may not contain what they advertise,” stated Jason Murphy, the director of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor linked the surge in demand to current cost increases for approved slimming drugs such as Mounjaro. “With prices rising, patients are using online platforms. But fake treatments are extremely dangerous. You can’t be certain what’s inside or whether the environment they were made in was clean,” she said.
Her team has already seen patients harmed by personal administration from unconfirmed sources. “We recognize the frustration, but buying from Telegram or WhatsApp is gambling with your well-being,” said Wyllie. “These materials could be impure or incorrectly dosed.”
Producer Position
A representative from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency globally. “Therefore at this point no one can sell [it] for personal consumption,” they explained, noting that any item “misleadingly claiming itself as a Lilly investigational substance not yet approved … may expose users to possibly serious medical dangers”.
